Eloxx Pharmaceuticals, Inc.
ELOX · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $13 | $9 | $5 | $4 |
| - Cash | $5 | $4 | $5 | $19 |
| + Debt | $6 | $6 | $6 | $13 |
| Enterprise Value | $14 | $10 | $7 | -$2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | -$4 | -$6 | -$6 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$4 | -$6 | -$6 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.31 | -1.96 | -2.88 | -2.92 |
| % Growth | 33.2% | 31.9% | 1.4% | – |
| Operating Cash Flow | -$3 | -$2 | -$7 | -$6 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$3 | -$2 | -$7 | -$6 |